The retrospective cohort study for survival rate in patients with advanced hepatocellular carcinoma receiving radiotherapy or palliative care
1
조회
0
다운로드
2
인용
0
참고문헌
키워드
초록
Background/Aims: This study was conducted to investigate the assessment of treatment efficacy of radiotherapy (RT) and other therapeutic modalities compared with palliative care only for treatment with advanced hepatocellular carcinoma (HCC). Methods: From 2002 to 2010, based on the case of 47 patients with advanced HCC, we have investigated each patients'Child-Pugh's class, ECOG performance, serum level of alpha fetoprotein and other baseline characteristics that is considered to be predictive variables and values for prognosis of HCC. Out of overall patients, the 29 patients who had received RT were selected for one group and the 18 patients who had received only palliative care were classified for the other. The analysis in survival between the two groups was done to investigate the efficacy of RT. Results: Under the analysis in survival, the mean survival time of total patients group was revealed between 30.1 months and 45.9 months in RT group, while it was 4.8 months in palliative care group, respectively. In the univariate analysis for overall patients, there were significant factors which affected survival rate like as follows: ECOG performance, Child-Pugh's class, the tumor size, the type of tumor, alpha fetoprotein,transarterial chemoembolization, and RT. The regressive analysis in multivariate Cox for total patients. No treatment under radiotherapy and high level of Child-Pugh's class grade were independent predictors of worse overall survival rate in patients. In contrast, for the subset analysis of the twenty-nine patients treated with radiotherapy, the higher serum level of alpha fetoprotein was an independent predictors of worse overall survival rate in patients. Conclusions: We found that the survival of patients with advanced HCC was better with radiotherapy than with palliative care. Therefore, radiotherapy could be a good option for in patients with advanced HCC.
Abstract
Background/Aims: This study was conducted to investigate the assessment of treatment efficacy of radiotherapy (RT) and other therapeutic modalities compared with palliative care only for treatment with advanced hepatocellular carcinoma (HCC). Methods: From 2002 to 2010, based on the case of 47 patients with advanced HCC, we have investigated each patients'Child-Pugh's class, ECOG performance, serum level of alpha fetoprotein and other baseline characteristics that is considered to be predictive variables and values for prognosis of HCC. Out of overall patients, the 29 patients who had received RT were selected for one group and the 18 patients who had received only palliative care were classified for the other. The analysis in survival between the two groups was done to investigate the efficacy of RT. Results: Under the analysis in survival, the mean survival time of total patients group was revealed between 30.1 months and 45.9 months in RT group, while it was 4.8 months in palliative care group, respectively. In the univariate analysis for overall patients, there were significant factors which affected survival rate like as follows: ECOG performance, Child-Pugh's class, the tumor size, the type of tumor, alpha fetoprotein,transarterial chemoembolization, and RT. The regressive analysis in multivariate Cox for total patients. No treatment under radiotherapy and high level of Child-Pugh's class grade were independent predictors of worse overall survival rate in patients. In contrast, for the subset analysis of the twenty-nine patients treated with radiotherapy, the higher serum level of alpha fetoprotein was an independent predictors of worse overall survival rate in patients. Conclusions: We found that the survival of patients with advanced HCC was better with radiotherapy than with palliative care. Therefore, radiotherapy could be a good option for in patients with advanced HCC.
참고문헌 (33)
- "National Cancer Information Center (NCIC)" (2008)[URL]
- Dusheiko GM, "Treatment of small hepatocellular carcinomas", Lancet, 340, pp.285~288 (1992)
- Mori W, "Cirrhosis and primary cancer of the liver. Comparative study in Tokyo and Cincinnati", Cancer, 20, pp.627~631 (1967)
- Hawkins MA, "Radiation therapy for hepatocellular carcinoma: from palliation to cure", Cancer, 106, pp.1653~1663 (2006)
- Guo WJ, "The long-term efficacy of combined chemoembolization and local irradiation in the treatment of patients with large hepatocellular carcinoma", Hepatogastroenterology, 50, pp.500~503 (2003)
- Dawson LA, "Partial volume tolerance of the liver to radiation", Semin Radiat Oncol, 15, pp.279~283 (2005)
- 박희철, "Clinical results and prognostic factors in radiotherapy for unresectable hepatocellular carcinoma: A retrospective study of 158 patients", INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 55, pp.329~336, ELSEVIER SCIENCE INC
- Kim TH, "Dose-volumetric parameters predicting radiation-induced hepatic toxicity in unresectable hepatocellular carcinoma patients treated with threedimensional conformal radiotherapy", Int J Radiat Oncol Biol Phys, 67, pp.225~231 (2007)
- Seong J, "Combined transcatheter arterial chemoembolization and local radiotherapy of unresectable hepatocellular carcinoma", Int J Radiat Oncol Biol Phys, 43, pp.393~397 (1999)
- Dhir V, "Combination chemotherapy and radiation for palliation of hepatocellular carcinoma", Am J Clin Oncol, 15, pp.304~307 (1992)
- Martins A, "Treatment and prognostic factors in patients with hepatocellular carcinoma", Liver Int, 26, pp.680~687 (2006)
- 김정훈, "진행된 간세포암에서의 간문맥 혈전증에 대한 방사선치료 결과", Radiation oncology journal, 25(3), pp.170~176 (2007), 대한방사선종양학회
- Kim DY, "Three-dimensional conformal radiotherapy for portal vein thrombosis of hepatocellular carcinoma", Cancer, 103, pp.2419~2426 (2005)
- Yamada K, "Prospective trial of combined transcatheter arterial chemoembolization and three-dimensional conformal radiotherapy for portal vein tumor thrombus in patients with unresectable hepatocellular carcinoma", Int J Radiat Oncol Biol Phys, 57, pp.113~119 (2003)
- Zeng ZC, "A comparison of treatment combinations with and without radiotherapy for hepatocellular carcinoma with portal vein and", or inferior vena cava tumor thrombus, 2005, pp.61, 432~443
- Meng MB, "Transcatheter arterial chemoembolization in combination with radiotherapy for unresectable hepatocellular carcinoma: a systematic review and meta-analysis", Radiother Oncol, 92, pp.184~194 (2009)
- Cheng SH, "A pilot study of three-dimensional conformal radiotherapy in unresectable hepatocellular carcinoma", J Gastroenterol Hepatol, 14, pp.1025~1033 (1999)
- Huang JF, "Incidence and clinical outcome of icteric type hepatocellular carcinoma", J Gastroenterol Hepatol, 17, pp.190~195 (2002)
- Zeng ZC, "Consideration of role of radiotherapy for lymph node metastases in patients with HCC: retrospective analysis for prognostic factors from 125 patients", Int J Radiat Oncol Biol Phys, 63, pp.1067~1076 (2005)
- Llovet JM, "Prognosis of hepatocellular carcinoma: the BCLC staging classification", Semin Liver Dis, 19, pp.329~338 (1999)
- Yuki K, "Growth and spread of hepatocellular carcinoma. A review of 240 consecutive autopsy cases", Cancer, 66, pp.2174~2179 (1990)
- Korean Liver Cancer Study Group, "Practice guidelines for management of hepatocellular carcinoma 2009", Korean J Hepatol, 15, pp.391~423 (2009)
- "WHO Definition of Palliative Care" (2011)[URL]
- Oken MM, "Toxicity and response criteria of the Eastern Cooperative Oncology Group", Am J Clin Oncol, 5, pp.649~655 (1982)
- 김영일, "Three-dimensional conformal radiotherapy of unresectable hepatocellular carcinoma patients for whom transcatheter arterial chemoembolization was ineffective or unsuitable", American journal of clinical oncology : the official publication of the American Radium Society, 29(6), pp.568~575 (2006), Lippincott Williams & Wilkins Ltd.
- Eisenhauer EA, "New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)", Eur J Cancer, 45, pp.228~247 (2009)
- Park W, "Local radiotherapy for patients with unresectable hepatocellular carcinoma", INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 61, pp.1143~1150 (2005), ELSEVIER SCIENCE INC
- Lawrence TS, "Treatment of cancers involving the liver and porta hepatis with external beam irradiation and intraarterial hepatic fluorodeoxyuridine", Int J Radiat Oncol Biol Phys, 20, pp.555~561 (1991)
- 금기창, "절제 불가능한 원발성 간암의 입체조형 방사선치료의 초기 임상 결과", Radiation oncology journal, 20(2), pp.5~129 (2002), 대한방사선종양학회
- Seong J, "Combined transcatheter arterial chemoembolization and local radiotherapy of unresectable hepatocellular carcinoma", Int J Radiat Oncol Biol Phys, 43, pp.393~397 (1999)
- Grieco A, "Prognostic factors for survival in patients with early-intermediate hepatocellular carcinoma undergoing non-surgical therapy: comparison of Okuda, CLIP, and BCLC staging systems in a single Italian centre", Gut, 54, pp.411~418 (2005)
- Pompili M, "Prognostic factors for survival in patients with compensated cirrhosis and small hepatocellular carcinoma after percutaneous ethanol injection therapy", Cancer, 92, pp.126~135 (2001)
- Lencioni R, "Treatment of small hepatocellular carcinoma with percutaneous ethanol injection. Analysis of prognostic factors in 105 Western patients", Cancer, 76, pp.1737~1746 (1995)